Impact of SLGT2 inhibitors treatment initiation on the reduction of atrial and ventricular arrhythmias in patients with implanted cardiac device

Back

HFA Premium Access

Impact of SLGT2 inhibitors treatment initiation on the reduction of atrial and ventricular arrhythmias in patients with implanted cardiac device

Session: Arrhythmias in heart failure

Topic: Clinical

Speaker: Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Professor Jose Ramon Gonzalez Juanatey

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

22 presentations

3 followers

6 more presentations in this session

Fusion CRT pacing and LA reverse remodeling: the key for low incidence of atrial fibrillation in HF patients

Speaker: Doctor C. Vacarescu (Timisoara, RO)

Characterizing atrial fibrillation in patients with and without heart failure and across the ejection fraction spectrum: incidence, prevalence, and treatment strategies

Speaker: Doctor V. Valente (Solna, SE)

Heart failure detection from electrocardiogram using artificial intelligence

Speaker: Doctor A. Ranjbar (Oslo, NO)

Change of natriuretic peptides over time predicts new development of atrial fibrillation in at risk population

Speaker: Doctor C. Powell (Cork, IE)

Atrial fibrillation burden characteristics in heart failure patients with reduced versus preserved ejection fraction as detected by insertable cardiac monitors.

Speaker: Mr S. Sarkar (Moundsview, US)

Access the full session

Arrhythmias in heart failure

Speakers: Professor J. Gonzalez Juanatey, Doctor C. Vacarescu, Doctor V. Valente, Doctor A. Ranjbar, Doctor C. Powell...

Access

Video

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources